Conditions

Cannabinoids like CBD, CBG and the terpene caryophyllene are anti-inflammatory in the lab, but human evidence is limited. What the science shows.…

Topical CBD is popular for arthritis and joint pain, and the biology is plausible, but strong human trial evidence is still limited.…

Early studies suggest cannabis may reduce migraines for some, but controlled trials are lacking. What the emerging evidence shows. Not medical advice.

PTSD is a common reason for cannabis use, but trial evidence is limited and inconclusive. What research shows and the cautions. Not…

Cannabis may speed sleep onset short-term but can reduce REM and build tolerance; CBN sleep claims are weak. What the emerging evidence…

Cannabis and anxiety is nuanced: CBD shows some promise, THC is biphasic and high doses often worsen anxiety. Why dose and ratio…

For MS muscle spasticity, a 1:1 THC:CBD spray (nabiximols/Sativex) is approved in many countries; evidence is moderate and patient-reported. Not medical advice.

Purified CBD (Epidiolex) is FDA-approved and trial-proven to reduce seizures in Dravet, Lennox-Gastaut and TSC. Why it differs from shop CBD. Not…

Nausea and appetite are among the most established cannabinoid uses, with FDA-approved THC medicines (dronabinol, nabilone) for chemotherapy and HIV wasting. Not…

Chronic pain is the best-supported use of cannabis: what the evidence shows, which compounds are studied, how people use it, and the…